Ex vivo mucosal cultures: an emerging player in vaccine development
Frontiers in Cellular and Infection Microbiology · 07.01.2026 · 15
DOI: 10.3389/fcimb.2025.1739617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 07.01.2026. Verfasst von Nikita Chilakamarri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Medicine and Pediatric Infectious Diseases, Center for Biomedical Education and Research (ZBAF), Department of Human Medi…. Hauptthemen laut MEDLINE: Vaccine Development, Mucous Membrane, Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität Witten/Herdecke.
Abstract (Originalsprache)
Increased awareness of pathogens with pandemic potential, especially respiratory viruses, is driving research on next-generation mucosal vaccines. However, clinical translation is still hampered by the lack of relevant experimental systems. Here, we review advances in human mucosal ex vivo cultures and their eligibility for vaccine development as an alternative to animal models. Ranging from organotypic air-liquid interface cultures to lymphoid organoids and microfluidics-based co-cultures, several breakthroughs occurred in recent years in modeling mucosa architecture and physiology, as well as adaptive immune responses. Advancing recent progress for clinical developments may require high-throughput approaches to validate the representativeness of the immune response within models, benchmark best practices for regulatory standardization, and investigate the influence of microbiota on mucosal immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Translational Medicine and Pediatric Infectious Diseases, Center for Biomedical Education and Research (ZBAF), Department of Human Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
- Virology and Microbiology, Center for Biomedical Education and Research (ZBAF), Department of Human Medicine, Witten/Herdecke University, Faculty of Health, Witten, Germany.
- Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
- Chair of Pediatrics, Children's Hospital, Vestische Kinder- und Jugendklinik Datteln, Witten/Herdecke University, Datteln, Germany.
- Institute for Medical Laboratory Diagnostics, Center for Clinical and Translational Research, Helios University Hospital Wuppertal, Witten/Herdecke University, Wuppertal, Germany.
Förderung
- Universität Witten/Herdecke
Zitieren
APA
Chilakamarri, N., Sallard, E., & Aydin, M. (2026). Ex vivo mucosal cultures: an emerging player in vaccine development. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1739617
Vancouver
Chilakamarri N, Sallard E, Aydin M. Ex vivo mucosal cultures: an emerging player in vaccine development. Frontiers in Cellular and Infection Microbiology. 2026;15. doi:10.3389/fcimb.2025.1739617
BibTeX
@article{Chilakamarri2026,
author = {Chilakamarri, Nikita and Sallard, Erwan and Aydin, Malik},
title = {Ex vivo mucosal cultures: an emerging player in vaccine development},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {15},
doi = {10.3389/fcimb.2025.1739617}
}
EUVIMED